Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR
Science Advances · 2023
DOI: 10.1126/sciadv.adg8014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Francesco Manfredi und 27 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS San Raffaele Scientific Institute, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, via Olgettin…. Hauptthemen laut MEDLINE: T-Cell Exhaustion, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Italian Ministry of Education, University and Research, Italian Ministry of Health and Alliance Against Cancer (Ricerca Corrente.
Abstract (Originalsprache)
To study and then harness the tumor-specific T cell dynamics after allogeneic hematopoietic stem cell transplant, we typed the frequency, phenotype, and function of lymphocytes directed against tumor-associated antigens (TAAs) in 39 consecutive transplanted patients, for 1 year after transplant. We showed that TAA-specific T cells circulated in 90% of patients but display a limited effector function associated to an exhaustion phenotype, particularly in the subgroup of patients deemed to relapse, where exhausted stem cell memory T cells accumulated. Accordingly, cancer-specific cytolytic functions were relevant only when the TAA-specific T cell receptors (TCRs) were transferred into healthy, genome-edited T cells. We then exploited trogocytosis and ligandome-on-chip technology to unveil the specificities of tumor-specific TCRs retrieved from the exhausted T cell pool. Overall, we showed that harnessing circulating TAA-specific and exhausted T cells allow to isolate TCRs against TAAs and previously not described acute myeloid leukemia antigens, potentially relevant for T cell–based cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- IRCCS San Raffaele Scientific Institute, Division of Immunology, Transplantation, and Infectious Diseases, Experimental Hematology Unit, via Olgettina 60, Milan 20132, Italy.
- IRCCS San Raffaele Scientific Institute, Hematology and Hematopoietic Stem Cell Transplantation Unit, via Olgettina 60, Milan 20132, Italy.
- Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, via Olgettina 60, Milan 20132, Italy.
- University of Helsinki, ImmunoVirotherapy Lab, Yliopistonkatu 4, 00100 Helsinki, Finland.
- IRCCS San Raffaele Scientific Institute, Division of Immunology, Transplantation and Infectious Disease, Unit of Immunogenetics, Leukemia Genomics and Immunobiology, via Olgettina 60, Milan 20132, Italy.
- Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institute, 171 65 Solna, Sweden.
ORCID-Profile: Francesco Manfredi, Lorena Stasi, Danilo Abbati, Alessia Potenza, Chiara Balestrieri, Beatrice Claudia Cianciotti, Elena Tassi, Sara Feola, Cristina Toffalori, Marco Punta, Zulma Magnani, Barbara Camisa, Elena Tiziano, Rui Mamede Branca, Janne Lehtiö, Tiina M Sikanen, Markus J Haapala, Vincenzo Cerullo, Monica Casucci, Luca Vago, Fabio Ciceri, Chiara Bonini, Eliana Ruggiero
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- Italian Ministry of Education, University and Research
- Italian Ministry of Health and Alliance Against Cancer (Ricerca Corrente
- Academy of Finland
Zitieren
APA
Manfredi, F., Stasi, L., Buonanno, S., Marzuttini, F., Noviello, M., Mastaglio, S., Abbati, D., Potenza, A., Balestrieri, C., Cianciotti, B. C., Tassi, E., Feola, S., Toffalori, C., Punta, M., Magnani, Z., Camisa, B., Tiziano, E., Lupo-Stanghellini, M. T., Branca, R. M., …, & Ruggiero, E. (2023). Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR. Science Advances. https://doi.org/10.1126/sciadv.adg8014
Vancouver
Manfredi F, Stasi L, Buonanno S, Marzuttini F, Noviello M, Mastaglio S, et al. Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR. Science Advances. 2023. doi:10.1126/sciadv.adg8014
BibTeX
@article{Manfredi2023,
author = {Manfredi, Francesco and Stasi, Lorena and Buonanno, Silvia and Marzuttini, Francesca and Noviello, Maddalena and Mastaglio, Sara and Abbati, Danilo and Potenza, Alessia and Balestrieri, Chiara and Cianciotti, Beatrice Claudia and Tassi, Elena and Feola, Sara and Toffalori, Cristina and Punta, Marco and Magnani, Zulma and Camisa, Barbara and Tiziano, Elena and Lupo-Stanghellini, Maria Teresa and Branca, Rui Mamede and Lehtiö, Janne and Sikanen, Tiina M and Haapala, Markus J and Cerullo, Vincenzo and Casucci, Monica and Vago, Luca and Ciceri, Fabio and Bonini, Chiara and Ruggiero, Eliana},
title = {Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adg8014}
}
EUVIMED